Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo

• T. N. A. van den Berg ,

  Contributed equally to this work with: T. N. A. van den Berg, S. El Messaoudi

  Affiliation Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• S. El Messaoudi ,

  Contributed equally to this work with: T. N. A. van den Berg, S. El Messaoudi

  Affiliation Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• G. A. Rongen,

  Affiliations Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands, Department of Internal Medicine (division of vascular medicine), Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• P. H. H. van den Broek,

  Affiliation Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• A. Bilos,

  Affiliation Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• A. R. T. Donders,

  Affiliation Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• M. E. Gomes,

  Affiliation Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

  ⨯
• N. P. Riksen

  * E-mail: niels.riksen@radboudumc.nl

  Affiliations Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands, Department of Internal Medicine (division of vascular medicine), Radboud university medical center, Nijmegen, The Netherlands

  ⨯